Key Highlights

  • Estee Lauder's fiscal first-quarter net sales reached $3.715 billion, a 7% increase, and the company lifted its fiscal 2027 diluted EPS range to $3.20 to $3.45.
  • Clorox brought in $1.905 billion of net sales, up 33%, and the GOJO deal contributed 15 percentage points of that growth.
  • Herbalife's net sales totaled $1,350.2 million, a 6.0% rise that marks five quarters of consecutive expansion.
  • BRC's net Revenue hit $108.0 million, increasing 7.3%, but the company ended with an $8.7 million net loss.
  • Choice Hotels International recorded $57.9 million of net income, compared with $180.0 million a year before.

Every Reporter in This Consumer Set Posted Top-Line Gains

All five consumer-oriented companies released quarterly figures around Nov 2, 2026, and each one showed higher sales or revenue. Estee Lauder (NYSE:EL) reported $3.715 billion in fiscal first-quarter net sales, a 7% gain, with $233 million of net Earnings and an improved fiscal 2027 view. Clorox (NYSE:CLX) recorded $1.905 billion of net sales for its fiscal first quarter, a 33% rise, and $170 million of net earnings.

Herbalife (NYSE:HLF) generated third-quarter sales of $1,350.2 million, 6.0% higher, and $58.8 million of net income. BRC (NYSE:BRCC) generated net revenue of $108.0 million, a 7.3% gain (calculated), but still lost $8.7 million on the bottom line. Choice Hotels International (NYSE:CHH) brought in $458.3 million of total revenues, roughly 2.5% above the prior level (calculated), and booked $57.9 million in net income.

Estee Lauder and Clorox use fiscal quarters, whereas the other three follow calendar third quarters. The sources of growth differ too: Clorox's increase is partly acquisition-driven and partly reflects a comparison period hurt by an ERP transition.

Estee Lauder: Fragrance Sales and Mainland China Carry the 7% Gain

Estee Lauder's net sales increased 7% from $3.481 billion, or 6% on an organic basis. Fragrance revenue rose 19% to $861 million. Growth showed up in three of four product categories and in every region, as Mainland China rose 15% to $614 million.

Net earnings reached $233 million, compared with $47 million a year before. Adjusting out restructuring and other charges, diluted EPS was $0.72, versus $0.32 previously. Gross Margin widened by 240 basis points to 75.7%.

The fiscal 2027 diluted EPS outlook moved up, from a $3.10 to $3.35 band to $3.20 to $3.45, and the organic growth outlook now runs 4% to 5.5%. The company's forecast assumes no additional geopolitical worsening and anticipates a stronger first half than second half.

Clorox: Acquisition and Easy Comparison Lift Sales, While Input Costs Mount

Clorox's net sales came to $1.905 billion, compared with $1.429 billion previously; organic growth was 18%, and the GOJO purchase added 15 points. Volume climbed 31%, partly because the earlier period was held back by the ERP transition. Diluted EPS jumped 114% to $1.39.

Gross margin slipped 130 basis points to 40.4% as commodity, Manufacturing and logistics expenses rose. The company's fiscal 2027 estimate for input cost Inflation now sits near $240 million, roughly $40 million above the first estimate.

Organic sales growth for the full year is now expected at 3.5% to 4.5%. Separately, the board appointed a new chief executive who starts in January.

Herbalife: Sustaining Momentum Through a Fifth Consecutive Quarter of Sales Growth

Herbalife's net sales grew 6.0% (7.6% in constant currency) on 8.6% volume growth. The India Business added $87 million, a 39% jump, while the EMEA region declined 4.9%. Net Income attributable to Herbalife climbed 36.1% to $58.8 million, equal to $0.55 per diluted share.

Herbalife distributes nutrition and wellness goods through independent distributors across more than 90 markets. The adjusted EBITDA figure was $182 million, a margin of 13.5%, and Leverage on a net basis was 2.0x.

Its full-year reported sales growth forecast moved up to 4.9% to 5.9%. For the fourth quarter, adjusted EBITDA is projected between $145 million and $165 million, under the third-quarter result. The company intends to start a $250 million buyback in the fourth quarter.

BRC: Impairments and a Legal Accrual Weigh on Revenue Gains

BRC, the Parent Company of Black Rifle Coffee Company, recorded net revenue of $108.0 million compared with $100.7 million in the comparison period. Wholesale sales grew to $72.5 million, an 8% increase, and direct-to-consumer sales climbed 8% to $30.2 million. Outpost sales, meanwhile, shrank 8%, landing at $5.4 million.

Gross margin improved to 37.1%, aided by about $3.5 million in Tariff refunds. Other Operating Expense rose from $0.6 million to $9.3 million, driven by Outpost impairments and a provision linked to a legal contingency. Taken together, those charges left BRC with a $7.5 million operating loss and an $8.7 million net loss, which works out to $0.28 for each Class A share.

Project Core calls for shutting 12 Outposts, with completion targeted for the conclusion of the first quarter in 2027. BRC signed a deal on Oct 29, 2026 to offload its Manchester Facility at a price of $17.0 million.

Choice Hotels International: One-Time Items Explain the Lower Profit, While Guidance Rises

Profit for the quarter was $57.9 million, equal to $1.28 per diluted share, against $180.0 million in the comparison period. That earlier figure contained a $100.0 million gain from buying out the rest of a joint venture stake. Results this period also carried a one-off $24.3 million cost tied to ending a purchase option, along with a $6.0 million impairment.

Adjusted diluted EPS grew roughly 11% to $2.33. U.S. RevPAR gained 3.8%, and occupancy improved 160 basis points. The franchisor's network includes 7,604 hotels totaling 660,614 rooms.

For 2026, the company projects adjusted EBITDA between $641 million and $651 million and adjusted EPS between $6.92 and $7.07. The Harvest Hosts purchase closed on Oct 1, 2026, at around $130 million.

Consumer Scorecard: Revenue Climbs Across the Board While Earnings Lag

Across the five names, revenue totals roughly $7.54 billion (calculated), while net income sums to about $511 million (calculated); the fiscal and calendar periods, however, do not line up. Average revenue growth, computed simply, was about 11.2% (calculated), falling to about 5.7% (calculated) once Clorox's acquisition-assisted 33% is excluded.

Net margin, measured as net income over revenue, sat at roughly 12.6% for Choice Hotels International (calculated) on the high end and dipped to a negative 8.1% at BRC (calculated) on the low end. Estee Lauder's revenue was roughly 34 times BRC's (calculated), a gap that signals very different scales.

Choice Hotels International, Herbalife and Estee Lauder all moved their outlooks higher. Clorox lifted its estimate for cost inflation, and BRC's article includes no forward guidance.

What to Watch Next: Nov 4 Investor Session, Dec 15 Payout and BRC's Outpost Exits

A Capital Markets event for Estee Lauder appears on the calendar for Wednesday, Nov 4, 2026; the article reached that date by inference from a transcript reference to 'this Wednesday'. Its $0.35 Dividend is due Dec 15, 2026, to shareholders of record on Nov 30, 2026.

Herbalife intends to start repurchases during the fourth quarter and roll out a common technology platform in the first quarter of 2027. BRC expects its 12 Outposts to be gone before the first quarter of 2027 ends, while Choice Hotels International plans to publish 2027 guidance in February.

Clorox's incoming chief executive begins in January, and its materials identified no dated event for second-quarter results.